Neo-B12 Injection contains the active ingredient hydroxocobalamin chloride (equivalent to hydroxocobalamin anhydrous 1000 micrograms), used to treat conditions due to vitamin B12 deficiency
It is expected to be commercially available in pharmacies in the second quarter of 2026
Mild, temporary sensations at the injection site may occur
These diverse and interconnected functions underscore the critical importance of mitochondria in maintaining cellular health and homeostasis, and perturbations in these processes have been linked to a wide range of diseases, including cardiovascular disorders and cognitive impairments, highlighting the need for further research into mitochondrial function and dysfunction
However, the cost of nurse time in administering the dose is enough to make health services consider saving some money and time by replacing injections with tablets
At TFLL Pharma, we are proud to provide high-purity, research-grade peptides to support your scientific investigations